2014
DOI: 10.1007/s12630-014-0211-0
|View full text |Cite
|
Sign up to set email alerts
|

Expanding the use of volatile anesthetic agents beyond the operating room

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…However, status asthmaticus is an intractable attack refractory to standard treatment that can lead to progressive respiratory failure [ 44 ]. Therefore, in refractory status asthmaticus, volatile anesthetics are also used for pediatric patients who do not respond well to conventional therapy [ 45 , 46 , 47 ]. The proposed mechanisms for volatile anesthetics include activating the β-adrenergic receptors, inhibiting acetylcholine and histamine release, and directly depressing airway reflexes and inducting bronchial smooth muscle relaxation that reverses the underlying airway bronchoconstriction [ 46 , 48 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, status asthmaticus is an intractable attack refractory to standard treatment that can lead to progressive respiratory failure [ 44 ]. Therefore, in refractory status asthmaticus, volatile anesthetics are also used for pediatric patients who do not respond well to conventional therapy [ 45 , 46 , 47 ]. The proposed mechanisms for volatile anesthetics include activating the β-adrenergic receptors, inhibiting acetylcholine and histamine release, and directly depressing airway reflexes and inducting bronchial smooth muscle relaxation that reverses the underlying airway bronchoconstriction [ 46 , 48 ].…”
Section: Discussionmentioning
confidence: 99%
“…[ 5 ] Nevertheless, volatile anesthetics have been used for refractory status asthmaticus in pediatric patients who do not respond to conventional therapy. [ 6 8 ] The proposed mechanisms for volatile anesthetics include activation of β-adrenergic receptor, direct bronchial smooth muscle relaxation by inhibition of acetylcholine and histamine release as well as addition of sedation that reverse the underlying bronchoconstriction. [ 7 , 9 ] Currently, the widespread and growing use of anesthesia in infants, defined as those less than 12 months of age, thus makes its safety an important health issue of interest to the public and government agencies.…”
Section: Introductionmentioning
confidence: 99%